Conexiant’s news site is now MDSpire News. Learn more
Advertisement
A More Direct Route to Intervention: Baptist Health Expands Surgical Pathways for Drug-Resistant Epilepsy
For patients who continue to have seizures despite appropriate anti-seizure medication therapy, timely referral for surgical evaluation can change the trajectory of care.
To enhance the surgical evaluation and treatment process for patients with drug-resistant epilepsy through advanced technologies.
Approach:
Robotic sEEG: Utilization of robotic stereo EEG (sEEG) to improve localization of seizure origins.
Responsive Neurostimulation: Increasing application of responsive neurostimulation (RNS) for patients ineligible for resection or ablation.
Multidisciplinary Pathway: Implementation of a coordinated multidisciplinary review to optimize the surgical pathway for epilepsy treatment.
Key Findings:
Timely referral for surgical evaluation can significantly change the care trajectory for patients with drug-resistant epilepsy.
Robotic sEEG enhances precision in electrode placement and reduces operative time.
Comprehensive evaluation can identify candidates for various treatment options, including resection, laser ablation, and neuromodulation.
Interpretation:
Identifying seizure origins is essential for determining suitable treatment pathways, which may include surgical options or ongoing medical management.
Limitations:
The article lacks specific data on patient outcomes or success rates associated with the new interventions.
There is no comparative analysis with other epilepsy centers provided.
Conclusion:
Baptist Health Miami Neuroscience Institute is advancing its approach to drug-resistant epilepsy through innovative technologies and collaborative care.
These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.